Desirox 500 mg (Deferasirox Tablets) contain deferasirox, an oral iron chelator designed to reduce excess iron in patients with chronic transfusion requirements, such as those with thalassemia major, myelodysplastic syndromes, or sickle cell disease. Desirox binds excess iron for elimination, helping prevent organ damage. Administered once daily, it offers convenient oral therapy for long-term management.
Select options
This product has multiple variants. The options may be chosen on the product page
Hydrea (Hydroxyurea Tablets) contains hydroxyurea, an antimetabolite used to reduce painful crises in sickle cell disease, manage polycythemia vera, and treat certain cancers including chronic myelogenous leukemia. Taken orally under medical supervision, Hydrea slows proliferation of abnormal cells and improves clinical outcomes.
Select options
This product has multiple variants. The options may be chosen on the product page
Revolade (Eltrombopag Tablets) contains eltrombopag, a thrombopoietin receptor agonist that stimulates platelet production. It’s used in adult and pediatric patients with chronic immune thrombocytopenia (ITP), severe aplastic anemia (SAA), and thrombocytopenia during hepatitis C treatment when low platelet levels impede therapy.
Select options
This product has multiple variants. The options may be chosen on the product page
End of content
End of content
“Sign up now and unlock a special 50% discount on your first purchase!”
Subscribe to our newsletter and get the latest trending products and offers updates.
Wait! before you leave…
We have something special for you
Use above code to get 50% off for your first order when checkout. Don't miss it.